SCHEMBL3405752

SCHEMBL3405752

COBNc1cn2nc(I)ccc2n1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.32
PIK3CD O00329 1/20 0.30
PIK3CG P48736 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13862032 0.78 PIK3CG (0.32) PIK3CAPIK3CG
SCHEMBL5954348 0.75 PDGFRB (0.31) PIK3CA
SCHEMBL2516569 0.71 PIK3CG (0.46) PIK3CAPIK3CDPIK3CG
SCHEMBL3486298 0.70 PIK3CA (0.40) PIK3CA
SCHEMBL254022 0.69 TTK (0.42) PIK3CA
SCHEMBL3394855 0.69 KDM4E (0.30)
SCHEMBL3405758 0.69 RAB9A (0.35)
SCHEMBL2517479 0.69 PIK3CG (0.43) PIK3CAPIK3CG
SCHEMBL2516313 0.69 PIK3CG (0.45) PIK3CAPIK3CG
SCHEMBL17856992 0.69 DYRK1A (0.53) PIK3CAPIK3CDPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012003338-A1 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-01-05 WO disclosed
WO-2010019899-A1 cMET INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-02-18 WO disclosed